soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM Oral Semaglutide Cuts Cardiovascular Risk

Tirzepatide is also available under the brand name Mounjaro , which is approved to treat type 2 diabetes

GLP-R in type 2 diabetes mellitus and obesity: an overview

Were finding these [obesity] medicines are quite popular, but we still have work to do to expand access, to improve affordability, Ricks said at the Jan

If you are ready to take the next step, visit Better You Rx, fill out the consultation form, or reach out directly at 1-647-576-2076 to learn more about accessing Retatrutide through our referral network.

This led to research in the use of liraglutide, semaglutide and tirzepatide for the purpose of chronic weight management